This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 1999;282:625.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A single oral dose of the antiretroviral drug nevirapine given to both an HIV-infected woman and her newborn infant provides the most practical and cheapest way to prevent transmission of the infection from mother to child, according to a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).

Researchers at Makerere University in Kampala, Uganda, and Johns Hopkins University in Baltimore gave one group of HIV-infected women a single dose of nevirapine during labor and another dose to their infants within 3 days of birth. A second group of HIV-infected women received a short course of zidovudine (AZT) every 3 hours from the onset of labor until delivery, and their infants were given the drug twice a day during the first week after birth.

The trial was halted when an analysis of interim data found that only 13.1% of infants from the nevirapine group . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?